Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-11-27
1991-07-16
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514336, 546 14, 546268, 546302, C07D21194, A61K 3144, A61K 31535
Patent
active
050326023
ABSTRACT:
For inhibiting HMG-CoA reductase and cholesterol synthesis, the novel 2-pyridones and pyrid-2-thiones of the formula ##STR1## in which A is optionally substituted aryl or heterocyclic,
REFERENCES:
Chem. Abstracts, 104:129776, Weber et al., Decker Oxidation of 2-Substituted N-alkylpyridinium Compounds, Chem. Ber., 1985, 118(10), p. 4086.
Angerbauer Rolf
Bischoff Hilmar
Fey Peter
Hubsch Walter
Petzinna Dieter
Bayer Aktiengesellschaft
Davis Peter
Lee Mary C.
LandOfFree
Inhibiting HMG-CoA reductase with novel substituted 2-pyridones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibiting HMG-CoA reductase with novel substituted 2-pyridones , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibiting HMG-CoA reductase with novel substituted 2-pyridones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-132094